Some $230 million has now been raised by Ring Therapeutics, a life sciences company founded by Flagship Pioneering with the aim of revolutionizing gene therapy 10 March 2023
Privately-held Swiss drugmaker Ferring was responsible for two out of the eight biological medicines approved by the US Food and Drug Administration’s (FDA) Cen 9 March 2023
A merger between Flamingo Therapeutics and Dynacure will create a new oncology company, retaining the Flamingo name, advancing lead candidates danvatirsen and F 3 March 2023
US pharma major AbbVie and privately-held gene therapy company Capsida Biotherapeutics have expanded their strategic collaboration on the development of genetic 23 February 2023
When new group chief executive Bill Anderson takes over at Bayer (BAYN: DE) in June, he will find a Pharmaceuticals Division that looks very different to the or 13 February 2023
Positive Phase III data for Bristol Myers-Squibb’s Abecma (idecabtagene vicleucel) underscore the potential of the firm’s CAR-T cell therapy in multiple myeloma 13 February 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.